Loading clinical trials...
Loading clinical trials...
The aim of this study is to define silent breast cancer prevalence in both sexes and will be held by biopsies performed in imaging suspicious areas of the breast (ecography and mammography) in cadavers without known breast cancer.
Cadavers of both sexes are going to be submitted to bilateral mastectomy. The specimens are going to be examined by palpation, ecography and mammography and all areas with (Breast Imaging Reporting and Data System) BI-RADS classification \>= 3 are going to be biopsied. Biopsy specimens are going to be processed by the pathology department and cancers are going to be identified and classified by their molecular type. The investigators intend to know which is the disease reservoir in various ages.
Age
40 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
September 1, 2016
Primary Completion Date
September 1, 2020
Completion Date
September 1, 2020
Last Updated
November 28, 2017
768
ESTIMATED participants
Bilateral mastectomy
PROCEDURE
Biopsy
OTHER
Lead Sponsor
Centro Hospitalar Lisboa Ocidental
Collaborators
NCT06332976
NCT06331793
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01703520